Angiogenesis inhibition is a therapeutic strategy aimed at blocking the formation of new blood vessels, thereby restricting tumor growth and metastasis by depriving cancer cells of nutrients and oxygen. This approach has been utilized in various cancer treatments, leveraging inhibitors that target specific pathways involved in angiogenesis, such as VEGF signaling.